3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Interventions
repotrectinib
1
pralsetinib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
entrectinib
1
cabozantinib
1
X-Rays
1
Specimen Handling
1
Phantoms, Imaging
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Neuroendocrine Tumors
×
Thalidomide
×
Clear all
No trials found.